farnesol has been researched along with Cancer of Lung in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dağ, İ; Feyzullazade, N; Şengel, T; Yilmaz Öztürk, B | 1 |
| Ahn, KS; Alharbi, SA; Chinnathambi, A; Lee, JH; Sethi, G; Shair, OHM | 1 |
| Qamar, W; Sultana, S | 1 |
| Biran, A; Brownstein, M; Haklai, R; Kloog, Y | 1 |
| Azzoli, CG; Ginsberg, MS; Johnson, ML; Kris, MG; Krug, LM; Medina, C; Miller, VA; Pao, W; Pietanza, MC; Riely, GJ; Rizvi, NA | 1 |
| Al-Mahdy, DA; Farag, MA | 1 |
| Elad-Sfadia, G; Haklai, R; Kloog, Y; Zundelevich, A | 1 |
| Hill, RP; Zhang, L | 1 |
| Collins, JB; Grissom, SF; Jetten, AM; Joo, JH; Liao, G | 1 |
| Jetten, AM; Joo, JH | 1 |
1 trial(s) available for farnesol and Cancer of Lung
| Article | Year |
|---|---|
A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; DNA, Neoplasm; Farnesol; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Salicylates; Survival Rate; Treatment Outcome | 2011 |
9 other study(ies) available for farnesol and Cancer of Lung
| Article | Year |
|---|---|
The investigation of in vitro effects of farnesol at different cancer cell lines.
Topics: Adenocarcinoma; Apoptosis; Caco-2 Cells; Cell Proliferation; Colonic Neoplasms; Farnesol; Humans; Lung Neoplasms | 2022 |
Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Farnesol; Female; Humans; Lung Neoplasms; Mice, Nude; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Wound Healing | 2019 |
Farnesol ameliorates massive inflammation, oxidative stress and lung injury induced by intratracheal instillation of cigarette smoke extract in rats: an initial step in lung chemoprevention.
Topics: Administration, Oral; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Edema; Farnesol; Hydrogen Peroxide; Inflammation; Lipid Peroxidation; Lung Injury; Lung Neoplasms; Male; Membrane Lipids; Nicotiana; Oxidative Stress; Phospholipids; Rats; Rats, Wistar; Smoke | 2008 |
Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinases; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Down-Regulation; Farnesol; Flow Cytometry; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Microtubule-Associated Proteins; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Salicylates; Survivin; Valproic Acid | 2011 |
Comparative study of the chemical composition and biological activities of Magnolia grandiflora and Magnolia virginiana flower essential oils.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Farnesol; Female; Flowers; Humans; Lung Neoplasms; Magnolia; Monocyclic Sesquiterpenes; Oils, Volatile; Phenylethyl Alcohol; Sesquiterpenes; Sesquiterpenes, Germacrane; Species Specificity | 2013 |
Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid).
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Farnesol; Humans; Lung Neoplasms; Mice; Mice, Nude; ras Proteins; Salicylates | 2007 |
Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion.
Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Farnesol; Fibrosarcoma; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice; Mice, SCID; Neoplasm Transplantation; Salicylates; Transplantation, Heterologous | 2007 |
Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response.
Topics: Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Farnesol; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; RNA, Small Interfering | 2007 |
NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway.
Topics: Cell Line, Tumor; Farnesol; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Lung Neoplasms; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; NF-KappaB Inhibitor alpha; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Transcription Factor RelA; Transcriptional Activation | 2008 |